These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 22198713)

  • 1. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference targeting Fas protects mice from fulminant hepatitis.
    Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
    Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic application of RNA interference for hepatitis C virus.
    Watanabe T; Umehara T; Kohara M
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
    Kim SI; Shin D; Lee H; Ahn BY; Yoon Y; Kim M
    J Hepatol; 2009 Mar; 50(3):479-88. PubMed ID: 19155084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of RNAi in the treatment of HCV infection.
    Volarevic M; Smolic R; Wu CH; Wu GY
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):823-31. PubMed ID: 17914916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.
    Zhang J; Yamada O; Sakamoto T; Yoshida H; Iwai T; Matsushita Y; Shimamura H; Araki H; Shimotohno K
    Virology; 2004 Mar; 320(1):135-43. PubMed ID: 15003869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of hepatic fibrosis by NK cell activation.
    Muhanna N; Abu Tair L; Doron S; Amer J; Azzeh M; Mahamid M; Friedman S; Safadi R
    Gut; 2011 Jan; 60(1):90-8. PubMed ID: 20660699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.
    Wang Q; Contag CH; Ilves H; Johnston BH; Kaspar RL
    Mol Ther; 2005 Sep; 12(3):562-8. PubMed ID: 15953767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interfering with hepatitis C virus RNA replication.
    Randall G; Rice CM
    Virus Res; 2004 Jun; 102(1):19-25. PubMed ID: 15068876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
    Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
    Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of small regulatory RNAs on the viral infection--new strategies in HCV therapy].
    Figlerowicz M; Tyczewska A; Figlerowicz M
    Przegl Epidemiol; 2006; 60(4):693-700. PubMed ID: 17682750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
    Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
    Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.
    Watanabe T; Sudoh M; Miyagishi M; Akashi H; Arai M; Inoue K; Taira K; Yoshiba M; Kohara M
    Gene Ther; 2006 Jun; 13(11):883-92. PubMed ID: 16496015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone.
    Maeda N; Watanabe M; Okamoto S; Kanai T; Yamada T; Hata J; Hozumi N; Katsume A; Nuriya H; Sandhu J; Ishii H; Kohara M; Hibi T
    Liver Int; 2004 Jun; 24(3):259-67. PubMed ID: 15189278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.